I J Fidler, G Poste. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acetylmuramyl-Alanyl-Isoglutamine/pharmacologyAcetylmuramyl-Alanyl-Isoglutamine/therapeutic useAdjuvants, Immunologic/pharmacologyAnimalsCell CommunicationCell MovementCell Transformation, Neoplastic/immunologyCytotoxicity, ImmunologicFibrosarcoma/immunologyHumansImmunization, PassiveLiposomes/administration & dosageLung Neoplasms/secondaryLymphokines/therapeutic useLymphoma/secondaryMacrophage ActivationMacrophages/drug effectsMacrophages/immunologyMacrophages/physiologyMelanoma/immunologyMelanoma/therapyMiceNeoplasm Metastasis/therapy
Substances: See more » Adjuvants, ImmunologicLiposomesLymphokinesAcetylmuramyl-Alanyl-Isoglutamine
Year: 1982 PMID: 6755782 DOI: 10.1007/bf00199794
Source DB: PubMed Journal: Springer Semin Immunopathol ISSN: 0344-4325